Literature DB >> 17028572

[Continuous subcutaneous infusion of apomorphine for the treatment of Parkinson's disease].

S Drapier1, M Vérin.   

Abstract

Apomorphine administered by subcutaneous infusion has been used efficiently in parkinsonian patients to treat severe motor fluctuations and levodopa-induced dyskinesias. Despite increasing evidence of its efficacy and its relative safety, apomorphine infusion therapy is still underused. This article reviews pharmacokinetic properties, efficacy, tolerability and indications of apomorphine infusion in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028572     DOI: 10.1016/s0035-3787(06)75115-3

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  1 in total

1.  The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.

Authors:  O Băjenaru; A Ene; B O Popescu; J A Szász; M Sabău; D F Mureşan; L Perju-Dumbrava; C D Popescu; A Constantinescu; I Buraga; M Simu
Journal:  J Neural Transm (Vienna)       Date:  2015-12-23       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.